Predictors of relapse and evaluation of the role of postoperative radiation therapy in a modern series of patients with surgically resected stage III (N2) non–small cell lung cancer
Sign Up to like & getrecommendations! Published in 2017 at "Advances in Radiation Oncology"
DOI: 10.1016/j.adro.2016.12.004
Abstract: Purpose For patients with stage III (N2) non–small cell lung cancer (NSCLC) treated with surgical resection, postoperative chemotherapy improves overall survival (OS), but the role of postoperative radiation therapy (PORT) is controversial. The purpose of… read more here.
Keywords: stage iii; series patients; resected stage; modern series ... See more keywords